Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...

Among individuals who play ice hockey, a diagnosis of chronic traumatic encephalopathy (CTE) increases with each year of play ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Alkermes Plc (NASDAQ:ALKS) reported strong financial results for the fourth quarter of 2024, surpassing earnings per share (EPS) and revenue forecasts. The company's EPS stood at $1.05, significantly ...

We read every piece of feedback, and take your input very seriously.